These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31986405)

  • 1. Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis.
    Zhao W; Wang B; Liu Y; Fu L; Sheng L; Zhao H; Lu Y; Zhang D
    Eur J Med Chem; 2020 Mar; 189():112075. PubMed ID: 31986405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
    Ng PS; Manjunatha UH; Rao SP; Camacho LR; Ma NL; Herve M; Noble CG; Goh A; Peukert S; Diagana TT; Smith PW; Kondreddi RR
    Eur J Med Chem; 2015 Dec; 106():144-56. PubMed ID: 26544629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
    Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.
    Wang X; Zhao W; Wang B; Ding W; Guo H; Zhao H; Meng J; Liu S; Lu Y; Liu Y; Zhang D
    Bioorg Chem; 2021 Sep; 114():105110. PubMed ID: 34175719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.
    Qin R; Wang P; Wang B; Fu L; Batt SM; Besra GS; Wu C; Wang Y; Huang H; Lu Y; Li G
    Eur J Med Chem; 2022 Mar; 231():114145. PubMed ID: 35101648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of less lipophilic riminophenazine derivatives for the treatment of drug-resistant tuberculosis.
    Zhang D; Lu Y; Liu K; Liu B; Wang J; Zhang G; Zhang H; Liu Y; Wang B; Zheng M; Fu L; Hou Y; Gong N; Lv Y; Li C; Cooper CB; Upton AM; Yin D; Ma Z; Huang H
    J Med Chem; 2012 Oct; 55(19):8409-17. PubMed ID: 22931472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
    Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
    J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring.
    Termentzi A; Khouri I; Gaslonde T; Prado S; Saint-Joanis B; Bardou F; Amanatiadou EP; Vizirianakis IS; Kordulakova J; Jackson M; Brosch R; Janin YL; Daffé M; Tillequin F; Michel S
    Eur J Med Chem; 2010 Dec; 45(12):5833-47. PubMed ID: 20961671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
    Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
    Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
    Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
    Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agents.
    Zhang D; Liu Y; Zhang C; Zhang H; Wang B; Xu J; Fu L; Yin D; Cooper CB; Ma Z; Lu Y; Huang H
    Molecules; 2014 Apr; 19(4):4380-94. PubMed ID: 24722591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.
    Aggarwal A; Parai MK; Shetty N; Wallis D; Woolhiser L; Hastings C; Dutta NK; Galaviz S; Dhakal RC; Shrestha R; Wakabayashi S; Walpole C; Matthews D; Floyd D; Scullion P; Riley J; Epemolu O; Norval S; Snavely T; Robertson GT; Rubin EJ; Ioerger TR; Sirgel FA; van der Merwe R; van Helden PD; Keller P; Böttger EC; Karakousis PC; Lenaerts AJ; Sacchettini JC
    Cell; 2017 Jul; 170(2):249-259.e25. PubMed ID: 28669536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis.
    Rao SP; Lakshminarayana SB; Kondreddi RR; Herve M; Camacho LR; Bifani P; Kalapala SK; Jiricek J; Ma NL; Tan BH; Ng SH; Nanjundappa M; Ravindran S; Seah PG; Thayalan P; Lim SH; Lee BH; Goh A; Barnes WS; Chen Z; Gagaring K; Chatterjee AK; Pethe K; Kuhen K; Walker J; Feng G; Babu S; Zhang L; Blasco F; Beer D; Weaver M; Dartois V; Glynne R; Dick T; Smith PW; Diagana TT; Manjunatha UH
    Sci Transl Med; 2013 Dec; 5(214):214ra168. PubMed ID: 24307692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis.
    Li P; Wang B; Fu L; Guo K; Ma C; Wang B; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2021 Oct; 222():113603. PubMed ID: 34126456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.
    Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
    Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.